KevinBradleyKaisermanMD
Pediatric Endocrinology • Torrance, CAAssistant Professor, Pediatrics, UCLA School of Medicine
Dr. Kaiserman is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
3400 Lomita Blvd
Ste 300
Torrance, CA 90505Phone+1 310-962-1808Fax+1 877-482-9800- Is this information wrong?
Education & Training
UCLA David Geffen School of Medicine/UCLA Medical CenterFellowship, Pediatric Endocrinology, 1995 - 1998- UCLA David Geffen School of Medicine/UCLA Medical CenterResidency, Pediatrics, 1992 - 1995
Eastern Virginia Medical SchoolClass of 1992
Certifications & Licensure
CA State Medical License 1994 - 2026- American Board of Pediatrics Pediatric Endocrinology
Clinical Trials
- Post Approval Study of the TS Feature With the 530G Pump System Supplemented With Commercial Patient Data Start of enrollment: 2013 Nov 26
- Safety Evaluation of the Hybrid Closed Loop (HCL) System in Pediatric Subjects With Type 1 Diabetes Start of enrollment: 2016 Apr 18
- Safety Evaluation of the Advanced Hybrid Closed Loop (AHCL) System Start of enrollment: 2019 Jul 24
Publications & Presentations
PubMed
- 32 citationsGlycemic outcomes of children 2-6 years of age with type 1 diabetes during the pediatric MiniMed™ 670G system trial.Gregory P Forlenza, Laya Ekhlaspour, Linda A DiMeglio, Larry A Fox, Henry Rodriguez, Dorothy I Shulman, Kevin B Kaiserman, David R Liljenquist, John Shin, Scott W Lee,...> ;Pediatric Diabetes. 2022 May 1
- 129 citationsSafety Evaluation of the MiniMed 670G System in Children 7-13 Years of Age with Type 1 Diabetes.Gregory P. Forlenza, Orit Pinhas-Hamiel, David R Liljenquist, Dorothy I. Shulman, Timothy S. Bailey, Bruce W. Bode, Michael A Wood, Bruce A. Buckingham, Kevin B Kaiser...> ;Diabetes Technology & Therapeutics. 2019 Jan 8
- 18 citationsIn-Clinic Evaluation of the MiniMed 670G System "Suspend Before Low" Feature in Children with Type 1 Diabetes.Michael A Wood, Dorothy I. Shulman, Gregory P. Forlenza, Bruce W. Bode, Orit Pinhas-Hamiel, Bruce A. Buckingham, Kevin B Kaiserman, David R Liljenquist, Timothy S. Bai...> ;Diabetes Technology & Therapeutics. 2018 Oct 25
- Join now to see all
Press Mentions
- MannKind Presents Data at 21st Annual Diabetes Technology MeetingNovember 5th, 2021
- MannKind Announces Data Presentation at 14th International Conference on Advanced Technologies & Treatments for Diabetes (ATTD 2021) to Be Held Virtually June 2-5June 3rd, 2021
Medtronic Wins FDA’s Breakthrough Status for Closed-Loop Insulin SystemFebruary 19th, 2019- Join now to see all
Grant Support
- DAX1 Function In Adrenocortical DevelopmentNational Institute Of Diabetes And Digestive And Kidney Diseases1997
Hospital Affiliations
- Emanate Health Inter-Community HospitalCovina, California
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
